Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Bob Saget Enlists Ray Romano, Ken Jeong, John Stamos and a Secret Comedy Star for Scleroderma Research Foundation’s Fundraiser Cool Comedy - Hot Cuisine

April 11, 2019
Cool Comedy-Hot Cuisine memories (Photo: Business Wire)

LOS ANGELES--(BUSINESS WIRE)--Apr 11, 2019--Bob Saget, a tireless voice in the fight against Scleroderma, an often-fatal disease that took his sister’s life, brings some of his funniest friends together for an unforgettable night of comedy at Cool Comedy – Hot Cuisine, Thursday, April 25 at the Four Seasons Beverly Wilshire. Saget will be joined by pals Ken Jeong, Ray Romano, John Stamos, and a very special comedy star at the signature event. The Hot Cuisine part of the night will feature a Latin inspired multi course culinary extravaganza from celebrity chefs and restaurateurs, Susan Feniger, an SRF Board Member, and business partner, Mary Sue Milliken (Food Network’s Too Hot Tamales and Bravo’s Top Chef Masters ).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190411005154/en/

Cool Comedy-Hot Cuisine memories (Photo: Business Wire)

Also attending will be Norman Lear (icon), Candace Cameron-Bure, Jodie Sweetin, Adam Hagenbuch and John Brotherton ( Fuller House ), Kevin Connolly ( Entourage ) Doug Ellin ( Entourage ) Seth Green ( Robot Chicken ) Peri Gilpin ( Fraiser ), Jonathan Silverman ( Weekend at Bernie’s) with more TBA.

“The night is about finding a cure. All of our money goes right to research. The evening will have the best four course meal, the best wines, and the best talent you can have. We have raised over $48 million over the last 32 years through Cool Comedy – Hot Cuisine, ” says Bob Saget.

Since its founding in 1987 by patient and advocate Sharon Monsky, the Scleroderma Research Foundation has raised over $48 million which has gone directly to scleroderma research. The Scleroderma Research Foundation has taken a collaborative approach to research, bringing together some of the brightest minds in science to unravel the mystery of this complex autoimmune disease. As best put by Monsky: “I establish[ed] an organization that would bring the best of science and technology together in an effort to discover better treatments and a cure for people everywhere living with scleroderma.” Sharon lost her battle to the disease in 2002, but her vision lives on today.

Cool Comedy – Hot Cuisine celebrates the incredible accomplishments of the Scleroderma Research Foundation – America’s first and leading nonprofit investor in medical research – to find improved therapies and a cure for people living with scleroderma. The success of Cool Comedy – Hot Cuisine events held in Los Angeles and New York has raised considerable awareness for scleroderma and enabled the SRF to fund innovative research bringing hope and helping to improve the quality of life for patients suffering from this debilitating disease.

Individual tickets for Cool Comedy – Hot Cuisine start at $500, with tiered tables starting at $5,000. All money raised will benefit scleroderma research, and more information about the event, including how to purchase tickets or tables, can be found at srfcchc.org.

About Scleroderma and the Scleroderma Research Foundation:

The word scleroderma literally means “hard skin,” but the disease typically does much more than that, often affecting the internal organs with life-threatening consequences. In some cases, the joints and muscles are affected, resulting in severe pain and limited mobility. Vascular damage due to scleroderma can result in loss of fingers, toes and entire limbs. The symptoms and severity of scleroderma vary from one patient to another, and the course of the disease is often unpredictable. The disease usually effects women–who represent four out of every five patients–between the ages of 30 and 50; however, children and men of all ages and across all ethnic boundaries can also be affected.

Today, there is still no cure for scleroderma. Treatments are available for some–though not all–of the most serious complications. However, with a research program led by a world-class Scientific Advisory Board, the SRF is providing new hope for patients. The continued success of the Scleroderma Research Foundation is entirely dependent upon charitable gifts from individuals and corporations.

Chaired by Dr. Luke Evnin, managing partner of MPM Capital and dedicated investor in life sciences, the Foundation is enabling scientists from leading institutions across the nation and around the world to work together and develop an understanding of how the disease begins, progresses, and what can be done to slow, halt or reverse the disease process. For more information, call +1 (415) 834 9444 or visit www.srfcure.org.

Instagram: @srfcure
Twitter: @srfcure
Facebook: SRFcure

View source version on businesswire.com:https://www.businesswire.com/news/home/20190411005154/en/

CONTACT: Andrew Freedman

Andrew Freedman Public Relations




SOURCE: Scleroderma Research Foundation

Copyright Business Wire 2019.

PUB: 04/11/2019 08:14 AM/DISC: 04/11/2019 08:14 AM


All contents © copyright 2019 The Associated Press. All rights reserved.